(Q34415535)

2 August 2017

1 reference

title

Anxiety disorders and major depression, together or apart (English)

1 reference

2 August 2017

Levine J

1

1 reference

2 August 2017

Cole DP

series ordinal

2

1 reference

2 August 2017

Chengappa KN

series ordinal

3

1 reference

2 August 2017

Gershon S

series ordinal

4

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

published in

Depression and Anxiety

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

94-104

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

2 August 2017

cites work

1 reference

Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.

21 January 2018

1 reference

Double-blind pilot trial of desipramine versus fluoxetine in panic patients

21 January 2018

1 reference

Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.

21 January 2018

1 reference

Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications

21 January 2018

1 reference

Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.

21 January 2018

1 reference

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

21 January 2018

1 reference

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

21 January 2018

1 reference

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder

21 January 2018

1 reference

21 January 2018

1 reference

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

21 January 2018

1 reference

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

21 January 2018

1 reference

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

21 January 2018

1 reference

Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study

21 January 2018

1 reference

Symptoms of anxiety and symptoms of depression. Same genes, different environments?

21 January 2018

1 reference

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

Psychiatric reaction patterns to imipramine

21 January 2018

1 reference

Double-blind, controlled trial of inositol treatment of depression

21 January 2018

1 reference

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients.

21 January 2018

1 reference

Panic disorder and social phobia: possible implications of comorbid depression for drug therapy

21 January 2018

1 reference

Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.

21 January 2018

1 reference

Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies

21 January 2018

1 reference

Benzodiazepines as antidepressants: does GABA play a role in depression?

21 January 2018

1 reference

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

21 January 2018

1 reference

Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression

21 January 2018

1 reference

Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.

21 January 2018

1 reference

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

21 January 2018

1 reference

Clinical Effects of the 5-HT1A Partial Agonists in Depression

21 January 2018

1 reference

Paroxetine efficacy in the treatment of generalized anxiety disorder

21 January 2018

1 reference

Alprazolam vs amitriptyline in depressions with reduced REM latencies.

21 January 2018

1 reference

Benzodiazepines in Depressive Disorders

21 January 2018

1 reference

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

21 January 2018

1 reference

Blunted growth hormone response to clonidine in panic disorder patients

21 January 2018

1 reference

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

21 January 2018

1 reference

Pharmacotherapy of Social Phobia

21 January 2018

1 reference

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

21 January 2018

1 reference

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

21 January 2018

1 reference

7 January 2021

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

7 January 2021

Benzodiazepines for depression? A review of the literature

1 reference

7 January 2021

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

7 January 2021

Alprazolam compared to amitriptyline in the treatment of major depression

1 reference

7 January 2021

Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. II

1 reference

7 January 2021

Continuing dialogue on incentive bias.

1 reference

7 January 2021

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

7 January 2021

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone

1 reference

7 January 2021

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

7 January 2021

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

7 January 2021

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

7 January 2021

Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. I

1 reference

7 January 2021

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

7 January 2021

The effect of citalopram in panic disorder

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.1051

1 reference

2 August 2017

1 reference